查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1904698

伴侣动物疼痛管理疗法市场预测至2032年：按类型、形式、宠物类型、功能、分销管道、最终用户和地区分類的全球分析

Companion Animal Pain Management Therapies Market Forecasts to 2032 - Global Analysis By Type (Probiotics, Prebiotics, Postbiotics and Synbiotics), Form, Pet Type, Function, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的研究，预计到 2025 年，全球伴侣动物疼痛管理治疗市场价值将达到 20.6 亿美元，到 2032 年将达到 35 亿美元，预测期内复合年增长率为 7.8%。

伴侣动物疼痛管理疗法是指为支持和平衡伴侣动物的胃肠道菌丛而配製的膳食补充剂、功能性饲料和兽用营养产品。这些方案通常含有益生菌、益生元、后生元、消化酵素和合合益素，旨在改善营养吸收、增强免疫力、减少胃肠道疾病并促进宠物的整体健康。这些方案广泛应用于犬、猫和其他伴侣动物，可解决腹泻、食物过敏、压力引起的肠道菌丛失衡以及与老龄化相关的消化功能衰退等问题。这些方案源自于营养学和兽医学的传统，体现了人们对预防保健和宠物长期健康的日益关注。

宠物拟人化且不断上涨的医疗费用支出

宠物饲养已悄悄达到一个临界点。人们不再只是饲养动物，而是珍爱它们。家庭将宠物视为家庭成员，并给予相应的投入。可支配收入的增加、城市生活的兴起以及与宠物之间更深厚的情感纽带，都推动了人们对预防性医疗保健的需求，而非被动治疗。肠道健康解决方案与「滋养身体，预防疾病」这一古老的智慧完美契合。饲主主人越来越倾向于选择经临床验证的益生菌产品来增强免疫力、改善消化功能并延长寿命，这支撑着市场的稳定成长。

高成本产品

儘管人们对益生菌的认知度不断提高，但高昂的价格仍然是一大障碍。益生菌製剂依赖特殊菌株、先进的封装技术、低温运输物流以及监管合规，所有这些都推高了成本。在价格敏感的市场，尤其是在新兴经济体，宠物饲主往往不愿意长期补充益生菌。传统的餵食方式和对基础饮食的依赖进一步阻碍了益生菌的普及。在价格与日常消费水准更匹配之前，益生菌的市场渗透率可能仍将不均衡，尤其是在都市区和高所得市场。

产品创新与多元化

创新是这个市场真正焕发活力的关键所在。针对不同品种、年龄和健康状况的定製配方正在开闢新的增长途径。功能性零食、风味口香糖、滴剂和合益素配方，都提升了产品的易用性和吸引力。以科学为基础，将肠道健康与免疫力、皮肤状况和行为连结起来，增强了消费者的信任。那些在传统与现代营养之间取得平衡，并不断拓展产品形式与用途的品牌，将更有能力引领下一波成长浪潮，推动市场扩张。

监管和标籤方面的挑战

监管是这个市场的隐形守门人。宠物益生菌介于饲料、营养补充剂和治疗产品之间，处于灰色地带，不同地区的监管规定差异显着。菌株核准、允许的健康声明、标籤语言和检测要求等方面的差异，造成了合规的复杂性。对生产商而言，这意味着更高的成本和产品上市的延迟；对消费者而言，标籤不一致会削弱信任。如果没有统一的标准，监管的不确定性将继续对规模化生产和跨境扩张构成挑战。

新冠疫情的感染疾病：

疫情改变了人们对宠物照护的关注。封锁措施导致宠物饲养量激增，而人们健康意识的提高也促使饲主更加重视预防性营养。同时，供应链中断影响了原料采购和分销。电子商务蓬勃发展，成为营养补充品的主要销售管道。儘管短期内物流挑战确实存在，但长期影响是正面的。新冠疫情强化了人们的信念：对宠物而言，就像对人类一样，健康始于内在。

预计在预测期内，胶囊产品细分市场将占据最大的市场份额。

由于其精准性、稳定性和临床可靠性，预计胶囊剂型在预测期内将占据最大的市场份额。与粉末和液体相比，胶囊剂型能够实现精准给药，保护敏感的益生菌菌株，并具有更长的保质期。兽医经常推荐使用胶囊剂型来支持消化器官系统和免疫系统，这增强了消费者的信任。对于寻求可衡量、循证疗效的宠物饲主，胶囊剂型值得信赖，并被视为传统医疗实践的延伸，以适应现代宠物预防保健的需求。

预计在预测期内，小型动物细分市场将呈现最高的复合年增长率。

预计在预测期内，小型哺乳动物市场将呈现最高的成长率，这主要得益于宠物数量的增长以及人们对它们脆弱消化器官系统的日益关注。兔子、天竺鼠和仓鼠等动物容易出现肠道菌丛失衡，因此益生菌已成为必需品而非可选项。城市生活、兽医资源有限以及饲主知识的不断提高，都在推动预防性营养补充品的普及。随着人们对小众营养领域的关注度不断提高，针对小型哺乳动物的客製化肠道健康解决方案正成为一个蓬勃发展的市场。

占比最大的地区：

由于宠物饲养量的增加、快速的都市化以及可支配收入的增长，预计亚太地区将在预测期内占据最大的市场份额。中国、日本和韩国等国家正在经历一场向高端宠物照护和预防性营养转变的文化变革。长期以来对消化健康的重视与益生菌的普及自然契合。兽医基础设施的完善和先进宠物营养补充剂的日益普及进一步增强了该地区的需求，巩固了亚太地区的主导地位。

年复合成长率最高的地区：

在预测期内，北美预计将实现最高的复合年增长率，这主要得益于消费者对宠物营养的高度认知、兽医的强大影响力以及宠物营养的优质化。宠物饲主非常重视标籤检视，并愿意投资购买经过临床检验的肠道健康产品。宠物保险的普及、先进的研发能力以及快速的产品创新正在推动宠物营养产品的市场成长。随着预防保健深深植根于宠物饲养文化中，北美将继续引领这个不断发展的市场的创新和成长。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，提供主要国家的市场估算和预测以及复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 根据主要企业的产品系列、地理覆盖范围和策略联盟进行基准分析

目录

第一章执行摘要

第二章 前言

  • 摘要
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球伴侣动物疼痛管理疗法市场（按类型划分）

  • 益生菌
  • 益生元
  • 后生元
  • 合益素

6. 全球伴侣动物疼痛管理疗法市场（按类型划分）

  • 药片
  • 液体
  • 粉末
  • 胶囊
  • 点心

7. 全球伴侣动物疼痛管理治疗市场（依宠物类型划分）

  • 狗
  • 猫
  • 小型哺乳动物
  • 其他宠物类型

8. 全球伴侣动物疼痛管理疗法市场（依功能划分）

  • 消化/肠道健康
  • 皮肤和毛髮健康
  • 免疫调节
  • 口腔和牙齿健康
  • 新陈代谢/体重管理
  • 其他功能

9. 全球伴侣动物疼痛管理疗法市场（依通路划分）

  • 兽医诊所/宠物医院
  • 线上零售/电子商务
  • 宠物店
  • 超级市场和大卖场
  • 其他分销管道

10. 全球伴侣动物疼痛管理疗法市场（依最终用户划分）

  • 宠物饲主
  • 动物收容所和饲养员
  • 兽医专业人员

11. 全球伴侣动物疼痛管理疗法市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十三章：企业概况

  • Nestle Purina PetCare
  • Vetoquinol SA
  • Mars Petcare
  • Virbac
  • Hill's Pet Nutrition
  • PetAg, Inc.
  • DSM-Firmenich
  • AnimalBiome
  • Chr. Hansen Holding A/S
  • Swedencare AB
  • Novozymes A/S
  • Kemin Industries
  • Archer Daniels Midland（ADM）
  • Vetnique Labs
  • Evonik Industries AG
Product Code: SMRC32976

According to Stratistics MRC, the Global Companion Animal Pain Management Therapies Market is accounted for $2.06 billion in 2025 and is expected to reach $3.50 billion by 2032 growing at a CAGR of 7.8% during the forecast period. Companion Animal Pain Management Therapies refer to dietary supplements, functional feeds, and veterinary nutrition products formulated to support and balance the digestive microbiome of companion animals. These solutions typically include probiotics, prebiotics, postbiotics, digestive enzymes, and synbiotics designed to improve nutrient absorption, strengthen immunity, reduce gastrointestinal disorders, and enhance overall pet well-being. Used across dogs, cats, and other companion animals, they address issues such as diarrhea, food sensitivities, stress-related gut imbalance, and aging-related digestive decline. Rooted in nutritional science and veterinary tradition, these solutions reflect a growing emphasis on preventive care and long-term pet health.

Market Dynamics:

Driver:

Rising Pet Humanization & Healthcare Spending

Pet ownership has quietly crossed a threshold: animals are no longer kept, they are cared for. Across households, pets are treated as family, and families invest accordingly. Rising disposable incomes, urban lifestyles, and deeper emotional bonds are driving demand for preventive healthcare rather than reactive treatment. Gut health solutions fit this old wisdom perfectly nourish the body to avoid disease. Owners increasingly seek clinically backed probiotics to improve immunity, digestion, and longevity, sustaining steady market momentum.

Restraint:

High Product Costs

Despite growing awareness, premium pricing remains a stubborn barrier. Probiotic formulations rely on specialized strains, advanced encapsulation, cold-chain logistics, and regulatory compliance, all of which elevate costs. In price-sensitive markets, especially emerging economies, pet owners often hesitate to commit to long-term supplementation. Traditional feeding habits and reliance on basic diets further slow adoption. Until costs align more closely with everyday spending patterns, market penetration will remain uneven, particularly beyond urban and high-income segments.

Opportunity:

Product Innovation & Diversification

Innovation is where this market truly breathes. Customized formulations by species, age, breed, and health condition are opening new growth paths. Functional treats, flavored chews, liquid drops, and synbiotic blends are making compliance easier and more appealing. Science driven storytelling linking microbiome health to immunity, skin, and behavior strengthens consumer trust. Brands that balance tradition with modern nutritional science, while expanding formats and applications, are well positioned to lead the next growth wave. Thus, it drives the market expansion.

Threat:

Regulatory & Labeling Challenges

Regulation is the quiet gatekeeper of this market. Pet probiotics sit in a gray zone between feed, supplement, and therapeutic product, and rules differ sharply by region. Variations in strain approval, permissible health claims, labeling language, and testing requirements create compliance complexity. For manufacturers, this raises costs and slows product launches. For consumers, inconsistent labeling can erode trust. Unless harmonized standards emerge, regulatory uncertainty will continue to challenge scalability and cross-border expansion.

Covid-19 Impact:

The pandemic reshaped pet care priorities. Lockdowns fueled a surge in pet adoption, while heightened health awareness pushed owners toward preventive nutrition. At the same time, supply chain disruptions affected ingredient sourcing and distribution. E-commerce emerged stronger, becoming a primary sales channel for supplements. While short-term logistics challenges were real, the long-term effect was positive COVID-19 reinforced the belief that health begins within, for pets as much as for people.

The capsules segment is expected to be the largest during the forecast period

The capsules segment is expected to account for the largest market share during the forecast period, due to its precision, stability, and clinical credibility. Capsules allow accurate dosing, protect sensitive probiotic strains, and offer longer shelf life compared to powders or liquids. Veterinarians frequently recommend capsule formats for targeted digestive and immune support, reinforcing consumer confidence. For pet owners seeking measurable, science-backed outcomes, capsules feel dependable and serious an extension of traditional medical practice adapted for modern preventive pet care.

The small mammals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the small mammals segment is predicted to witness the highest growth rate, due to rising adoption and growing awareness of their fragile digestive systems. Animals such as rabbits, guinea pigs, and hamsters are highly prone to gut imbalance, making probiotics essential rather than optional. Urban living, limited veterinary access, and increased owner education are driving preventive supplementation. As niche nutrition gains attention, tailored gut health solutions for small mammals are emerging as a fast-growing opportunity.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to expanding pet ownership, rapid urbanization, and rising disposable incomes. Countries such as China, Japan, and South Korea are seeing a cultural shift toward premium pet care and preventive nutrition. Long-standing traditions that value digestive health align naturally with probiotic adoption. Improved veterinary infrastructure and growing availability of advanced pet supplements further strengthen regional demand, securing Asia Pacific's leading position.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to high awareness, strong veterinary influence, and premiumization of pet nutrition. Pet owners are highly label-conscious and willing to invest in clinically validated gut health products. Widespread pet insurance, advanced R&D capabilities and rapid product innovation accelerate adoption. With preventive care deeply embedded in pet ownership culture, North America continues to set the pace for innovation and growth in this evolving market.

Key players in the market

Some of the key players in Companion Animal Pain Management Therapies Market include Nestle Purina PetCare, Vetoquinol SA, Mars Petcare, Virbac, Hill's Pet Nutrition, PetAg, Inc., DSM-Firmenich, AnimalBiome, Chr. Hansen Holding A/S, Swedencare AB, Novozymes A/S, Kemin Industries, Archer Daniels Midland (ADM), Vetnique Labs and Evonik Industries AG.

Key Developments:

In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.

In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.

Types Covered:

  • Probiotics
  • Prebiotics
  • Postbiotics
  • Synbiotics

Forms Covered:

  • Pills
  • Liquids
  • Powders
  • Capsules
  • Treats & Snacks

Pet Types Covered:

  • Dogs
  • Cats
  • Small Mammals
  • Other Pet Types

Functions Covered:

  • Digestive / Gut Health
  • Skin & Coat Health
  • Immune Modulation
  • Oral & Dental Health
  • Metabolic & Weight Management
  • Other Functions

Distribution Channels Covered:

  • Veterinary Clinics / Pet Hospitals
  • Online Retail / E-commerce
  • Pet Shops
  • Supermarkets & Hypermarkets
  • Other Distribution Channels

End Users Covered:

  • Pet Owners
  • Animal Shelters & Breeders
  • Veterinary Professionals

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Companion Animal Pain Management Therapies Market, By Type

  • 5.1 Introduction
  • 5.2 Probiotics
  • 5.3 Prebiotics
  • 5.4 Postbiotics
  • 5.5 Synbiotics

6 Global Companion Animal Pain Management Therapies Market, By Form

  • 6.1 Introduction
  • 6.2 Pills
  • 6.3 Liquids
  • 6.4 Powders
  • 6.5 Capsules
  • 6.6 Treats & Snacks

7 Global Companion Animal Pain Management Therapies Market, By Pet Type

  • 7.1 Introduction
  • 7.2 Dogs
  • 7.3 Cats
  • 7.4 Small Mammals
  • 7.5 Other Pet Types

8 Global Companion Animal Pain Management Therapies Market, By Function

  • 8.1 Introduction
  • 8.2 Digestive / Gut Health
  • 8.3 Skin & Coat Health
  • 8.4 Immune Modulation
  • 8.5 Oral & Dental Health
  • 8.6 Metabolic & Weight Management
  • 8.7 Other Functions

9 Global Companion Animal Pain Management Therapies Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Veterinary Clinics / Pet Hospitals
  • 9.3 Online Retail / E-commerce
  • 9.4 Pet Shops
  • 9.5 Supermarkets & Hypermarkets
  • 9.6 Other Distribution Channels

10 Global Companion Animal Pain Management Therapies Market, By End User

  • 10.1 Introduction
  • 10.2 Pet Owners
  • 10.3 Animal Shelters & Breeders
  • 10.4 Veterinary Professionals

11 Global Companion Animal Pain Management Therapies Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Nestle Purina PetCare
  • 13.2 Vetoquinol SA
  • 13.3 Mars Petcare
  • 13.4 Virbac
  • 13.5 Hill's Pet Nutrition
  • 13.6 PetAg, Inc.
  • 13.7 DSM-Firmenich
  • 13.8 AnimalBiome
  • 13.9 Chr. Hansen Holding A/S
  • 13.10 Swedencare AB
  • 13.11 Novozymes A/S
  • 13.12 Kemin Industries
  • 13.13 Archer Daniels Midland (ADM)
  • 13.14 Vetnique Labs
  • 13.15 Evonik Industries AG

List of Tables

  • Table 1 Global Companion Animal Pain Management Therapies Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Companion Animal Pain Management Therapies Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Companion Animal Pain Management Therapies Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 4 Global Companion Animal Pain Management Therapies Market Outlook, By Prebiotics (2024-2032) ($MN)
  • Table 5 Global Companion Animal Pain Management Therapies Market Outlook, By Postbiotics (2024-2032) ($MN)
  • Table 6 Global Companion Animal Pain Management Therapies Market Outlook, By Synbiotics (2024-2032) ($MN)
  • Table 7 Global Companion Animal Pain Management Therapies Market Outlook, By Form (2024-2032) ($MN)
  • Table 8 Global Companion Animal Pain Management Therapies Market Outlook, By Pills (2024-2032) ($MN)
  • Table 9 Global Companion Animal Pain Management Therapies Market Outlook, By Liquids (2024-2032) ($MN)
  • Table 10 Global Companion Animal Pain Management Therapies Market Outlook, By Powders (2024-2032) ($MN)
  • Table 11 Global Companion Animal Pain Management Therapies Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 12 Global Companion Animal Pain Management Therapies Market Outlook, By Treats & Snacks (2024-2032) ($MN)
  • Table 13 Global Companion Animal Pain Management Therapies Market Outlook, By Pet Type (2024-2032) ($MN)
  • Table 14 Global Companion Animal Pain Management Therapies Market Outlook, By Dogs (2024-2032) ($MN)
  • Table 15 Global Companion Animal Pain Management Therapies Market Outlook, By Cats (2024-2032) ($MN)
  • Table 16 Global Companion Animal Pain Management Therapies Market Outlook, By Small Mammals (2024-2032) ($MN)
  • Table 17 Global Companion Animal Pain Management Therapies Market Outlook, By Other Pet Types (2024-2032) ($MN)
  • Table 18 Global Companion Animal Pain Management Therapies Market Outlook, By Function (2024-2032) ($MN)
  • Table 19 Global Companion Animal Pain Management Therapies Market Outlook, By Digestive / Gut Health (2024-2032) ($MN)
  • Table 20 Global Companion Animal Pain Management Therapies Market Outlook, By Skin & Coat Health (2024-2032) ($MN)
  • Table 21 Global Companion Animal Pain Management Therapies Market Outlook, By Immune Modulation (2024-2032) ($MN)
  • Table 22 Global Companion Animal Pain Management Therapies Market Outlook, By Oral & Dental Health (2024-2032) ($MN)
  • Table 23 Global Companion Animal Pain Management Therapies Market Outlook, By Metabolic & Weight Management (2024-2032) ($MN)
  • Table 24 Global Companion Animal Pain Management Therapies Market Outlook, By Other Functions (2024-2032) ($MN)
  • Table 25 Global Companion Animal Pain Management Therapies Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 26 Global Companion Animal Pain Management Therapies Market Outlook, By Veterinary Clinics / Pet Hospitals (2024-2032) ($MN)
  • Table 27 Global Companion Animal Pain Management Therapies Market Outlook, By Online Retail / E-commerce (2024-2032) ($MN)
  • Table 28 Global Companion Animal Pain Management Therapies Market Outlook, By Pet Shops (2024-2032) ($MN)
  • Table 29 Global Companion Animal Pain Management Therapies Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 30 Global Companion Animal Pain Management Therapies Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 31 Global Companion Animal Pain Management Therapies Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Companion Animal Pain Management Therapies Market Outlook, By Pet Owners (2024-2032) ($MN)
  • Table 33 Global Companion Animal Pain Management Therapies Market Outlook, By Animal Shelters & Breeders (2024-2032) ($MN)
  • Table 34 Global Companion Animal Pain Management Therapies Market Outlook, By Veterinary Professionals (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.